Below is the third and final segment of Sacrificial Virgins, a documentary about the HPV vaccine (Gardasil and Cervarix) which is in widespread use despite the fact that it was fast-tracked onto the market; its efficacy in preventing cancer has not been medically proven; there are serious questions about the vaccine's ingredients and safety trials; and it is causing severe injury and death in many young women and young men around the world. Pharmaceutical manufacturers and health authorities refuse to acknowledge there is a problem; and many members of the medical community continue to recommend the vaccine.
Watch the documentary and please share with others, especially parents who might be considering the HPV vaccine for their daughters and sons.
“I see parents in the supermarket studying more carefully the back of a box of cornflakes than ever consider what in goodness sakes they’re putting into their child’s body through this particular vaccination...I’d like to see more parents informed…where people actually take a responsibility for what on earth they put into their child’s body; and it is children that we’re taking about. Why in goodness sakes would you put this vaccine into a nine year old girl when her chance of getting cervical cancer at the average age of 52 or 53 is so low that she’s just as likely to be damaged by hitting her head falling off the back of a chair, quite frankly…”
Stephen Tunley, Director Sanevax, Australia
“There is a second adjuvant included in Cervarix which is essentially a lipid and so these two work together as the adjuvant in this particular HPV vaccine. All of the safety trials for Cervarix did not use the mixture of aluminium hydroxide and the lipid in their trials. They chose simply also to use the aluminium hydroxide only. So that’s one thing in itself you begin to ask...unusual questions about why that was the case. You also have to ask the question, why in the other major HPV vaccine, Gardasil; why have they used a completely new adjuvant, aluminium adjuvant? One which has essentially not been used before.”
Christopher Exley, PhD